GILENYA

Feb 9, 12
Other articles:
  • Oct 1, 2010 . I guess I'd call myself quietly disappointed and a little fatigued from this news. A
  • Learn about the prescription medication Gilenya (Fingolimod Capsules), drug
  • Sep 22, 2010 . The FDA today approved Gilenya, the first oral MS drug. The once-daily capsules
  • Dec 15, 2011 . ZURICH (Reuters) - A third late-stage trial of Novartis' multiple sclerosis drug
  • Sep 22, 2010 . Gilenya reduces the frequency of MS relapses (flare-ups) and helps slow the
  • For discussing the first oral disease modyfying drug, Gilenya.
  • A summary of what to expect when taking your first dose of GILENYA to treat your
  • Oct 26, 2010 . Information about fingolimod (Gilenya), an oral medication prescribed for the
  • Find out more about Gilenya, the first of its kind, scientifically innovative treatment
  • Mar 23, 2011 . Gilenya (fingolimod) is used to treat relapsing forms of multiple sclerosis in adults
  • Fingolimod (rINN, trade name Gilenya, Novartis) is an immunomodulating drug,
  • Jan 26, 2011 . The purpose of the Multi-National Gilenya Pregnancy Exposure Registry in
  • Jan 20, 2012 . European regulators are taking a closer look at Novartis' ($NVS) multiple
  • Gilenya (fingolimod) explained, including Oral MS medication for the treatment of
  • Dec 13, 2011 . Novartis AG said a multiple sclerosis patient died on Nov. 23 after starting
  • Dec 3, 2010 . The immunomodulator drug Gilenya (FTY720), marketed as the first oral
  • GILENYA (Fingolimod) drug information for Multiple sclerosis from MPR including
  • Jan 23, 2012 . The risks and benefits of Gilenya, a medication for multiple-sclerosis, is currently
  • Gilenya™ is a new class of medication called a sphingosine 1-phosphate
  • May 11, 2011 . A very well-written review of an orally-active drug for multiple sclerosis has just
  • Aug 8, 2011 . It was pointed out that Novartis's new Gilenya (fingolimod) is priced even higher
  • Jan 20, 2012 . The drug, Gilenya, was licensed last year in the European Union to treat a severe
  • Apr 27, 2011 . Novartis AG's multiple sclerosis pill Gilenya, which faces a threat from a rival
  • Jan 22, 2012 . (Updates with Novartis comment in ninth paragraph.) Jan. 20 (Bloomberg) --
  • Sep 22, 2010 . Until Now, Only Injectable Drugs for MS Have Been Available Read more by
  • Sep 22, 2010 . Gilenya becomes the first MS medication that can be taken daily in pill form, and
  • Gilenya, the first oral pill approved by the FDA is now available for people living
  • Novartis Gilenya MS Pill to Cost $48000/year. The first oral MS drug approved
  • Jan 10, 2012 . The purpose of this blog is to share my experiences with Gilenya. The holiday
  • Oct 6, 2010 . Gilenya is a prescription medicine used to treat multiple sclerosis (MS). This
  • Jan 23, 2012 . Europe's drug regulator said it is reviewing the benefits and risks of Novartis'
  • Gilenya Support Program. The medications available through this program are:
  • Dec 20, 2011 . Patients with MS should not stop taking Gilenya without talking to their healthcare
  • Gilenya (fingolimod) page with information on Gilenya (fingolimod) and Multiple
  • Sep 23, 2010 . Gilenya (pronounced as "Jil-EN-ee-ah") presents a new option for individuals
  • Learn about GILENYA (fingolimod), the multiple sclerosis treatment available in
  • Jan 23, 2012 . The US Food and Drugs Administration (FDA) and European Medicines Agency (
  • Jan 27, 2012 . GILENYA™ Coupon: Save up to $800 on your monthly costs for GILENYA (
  • Dec 20, 2011 . FDA Drug Safety Communication: Safety review of a reported death after the first
  • Drug information and side-effects for Gilenya (fingolimod)
  • Novartis drug Gilenya® (fingolimod) has more than 20000 patient-years of
  • Jan 20, 2012 . Health agencies on both sides of the Atlantic are investigating reports of 11
  • Do you know someone who died unexpectedly while taking the multiple sclerosis
  • GILENYA is a sphingosine 1-phosphate receptor modulator indicated for the
  • The GILENYA Go Program provides free and comprehensive support to people
  • Jan 20, 2012 . The European Medicines Agency, or EMA, said Friday that it has begun a review
  • Jan 23, 2012 . Last month the FDA launched a probe to investigate the safety of Novartis'
  • Dec 23, 2011 . The recent death of a patient taking Gilenya (fingolimod), while definitely a very

  • Sitemap